Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MACSI: DP-b99 in Acute Ischemic Stroke
NCT00893867Phase 3Terminated
- Sponsor
- D-Pharm
- Start
- Dec 2009
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of DP-b99 in ischemic stroke, sponsored by D-Pharm. Started Dec 2009; status: terminated.
02
Drugs
DP-b99
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00893867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00893867.